TENELIGLIPTIN: 172 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
172
Total FAERS Reports
18 (10.5%)
Deaths Reported
97
Hospitalizations
172
As Primary/Secondary Suspect
12
Life-Threatening
4
Disabilities
First Report: 20070316 · Latest Report: 20240522
What Are the Most Common TENELIGLIPTIN Side Effects?
#1 Most Reported
Pemphigoid
29 reports (16.9%)
#2 Most Reported
Renal impairment
8 reports (4.7%)
#3 Most Reported
Off label use
8 reports (4.7%)
All TENELIGLIPTIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pemphigoid | 29 | 16.9% | 2 | 15 |
| Hypoglycaemia | 8 | 4.7% | 1 | 5 |
| Off label use | 8 | 4.7% | 1 | 2 |
| Renal impairment | 8 | 4.7% | 3 | 5 |
| Altered state of consciousness | 7 | 4.1% | 1 | 5 |
| Diabetes mellitus inadequate control | 7 | 4.1% | 0 | 5 |
| Diabetes mellitus | 6 | 3.5% | 1 | 3 |
| Interstitial lung disease | 6 | 3.5% | 0 | 3 |
| Cerebral infarction | 5 | 2.9% | 0 | 5 |
| Drug eruption | 5 | 2.9% | 0 | 1 |
| Glycosylated haemoglobin increased | 5 | 2.9% | 0 | 3 |
| Hepatic function abnormal | 5 | 2.9% | 1 | 3 |
| Pruritus | 5 | 2.9% | 0 | 1 |
Who Reports TENELIGLIPTIN Side Effects? Age & Gender Data
Gender: 44.3% female, 55.7% male. Average age: 70.2 years. Most reports from: JP. View detailed demographics →
Is TENELIGLIPTIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2007 | 1 | 0 | 0 |
| 2013 | 1 | 1 | 0 |
| 2014 | 5 | 0 | 2 |
| 2015 | 27 | 0 | 20 |
| 2016 | 19 | 1 | 14 |
| 2017 | 15 | 3 | 6 |
| 2018 | 15 | 4 | 8 |
| 2019 | 10 | 1 | 3 |
| 2020 | 6 | 0 | 3 |
| 2021 | 5 | 1 | 3 |
| 2022 | 5 | 1 | 3 |
| 2023 | 6 | 0 | 3 |
| 2024 | 3 | 0 | 1 |
What Is TENELIGLIPTIN Used For?
| Indication | Reports |
|---|---|
| Type 2 diabetes mellitus | 73 |
| Product used for unknown indication | 42 |
| Diabetes mellitus | 31 |
TENELIGLIPTIN vs Alternatives: Which Is Safer?
TENELIGLIPTIN vs TENIPOSIDE
TENELIGLIPTIN vs TENOFOVIR
TENELIGLIPTIN vs TENOFOVIR ALAFENAMIDE
TENELIGLIPTIN vs TENOFOVIR DISOPROXIL
TENELIGLIPTIN vs TEPLIZUMAB-MZWV
TENELIGLIPTIN vs TEPOTINIB
TENELIGLIPTIN vs TEPROTUMUMAB
TENELIGLIPTIN vs TEPROTUMUMAB-TRBW
TENELIGLIPTIN vs TERAZOSIN
TENELIGLIPTIN vs TERAZOSIN\TERAZOSIN
Official FDA Label for TENELIGLIPTIN
Official prescribing information from the FDA-approved drug label.